Off-the-Shelf immune cell therapy tested for stubborn lupus
Disease control
Ongoing
This early-stage trial is testing a new cell therapy called AB-101 for adults with severe lupus or lupus-related kidney disease that hasn't improved with standard treatments. The therapy uses donated 'natural killer' immune cells, given alone or alongside antibody drugs, to try t…
Phase: PHASE1 • Sponsor: Artiva Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC